Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07243652 · ClinicalTrials.gov registry record · NA
I-DECIDE After Bronchiolitis Hospitalization
A NA study of Bronchiolitis Acute, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 2,700
- Enrollment target
- 20
- Study locations
NCT07243652: Recruiting NA study of Bronchiolitis Acute, sponsored by Seattle Children's Hospital.
NCT07243652 is a NA study of Bronchiolitis Acute that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 2,700 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07243652, a NA study of Bronchiolitis Acute, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,700 participants
- Enrollment target
- 20
- Study locations
Study Summary
Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis. The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.
Primary Outcome
Proportion of participants who are prescribed PRN follow-up
Conditions Studied
Interventions
- OTHER Moderate-Resource Implementation Strategy
- OTHER High-Resource Implementation Strategy
Study Locations (20)
California
- Adventist Health Lodi Memorial - Lodi
- Children's Hospital Los Angeles - Los Angeles
- Valley Children's Hospital - Madera
- Children's Hospital Orange County (CHOC) - Orange
- University of California Davis Children's Hospital - Sacramento
Arizona
- Phoenix Children's Hospital - Arrowhead Campus - Glendale
- Phoenix Children's Hospital - Phoenix
Connecticut
- Connecticut Children's Medical Center - Hartford
- Yale-New Haven Children's Hospital - New Haven
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- OSF Children's Hospital of Illinois - Peoria
Massachusetts
- Boston Children's Hospital - Boston
- Baystate Children's Hospital - Springfield
Alabama
- Children's of Alabama - Birmingham
Colorado
- Children's Hospital Colorado - Aurora
District of Columbia
- Children's National Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT07243652 shows while recruiting
NCT07243652 is an interventional study that assigns participants to a tested intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher).
The record links to 1 condition, with Bronchiolitis Acute appearing as the primary indexed condition, and to 2 interventions - of which Moderate-Resource Implementation Strategy is the first listed.
NCT07243652 names 20 study sites across 12 states, led by California, Arizona, Connecticut.
Frequently Asked Questions
What is clinical trial NCT07243652 about?
NCT07243652 is a clinical study titled "I-DECIDE After Bronchiolitis Hospitalization". Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it rema...
What is the current status of trial NCT07243652?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,700 participants. The study started on 2025-11-01. Estimated completion is 2029-12.
What conditions does trial NCT07243652 study?
This clinical trial studies the following conditions: Bronchiolitis Acute.
What interventions are being tested in trial NCT07243652?
The interventions under investigation include: Moderate-Resource Implementation Strategy (OTHER), High-Resource Implementation Strategy (OTHER).
Who is sponsoring clinical trial NCT07243652?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07243652 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07243652's enrollment target sits among peer trials
2,700 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI